Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study.

BJU international - 1 Jan 2022

Gordon Naheema S, Baxter Laura A, Goel Anshita, Arnold Roland, Kaur Baljit, Liu Wenyu, Pirrie Sarah J, Hussain Syed, Viney Richard, Ford Daniel, Zarkar Anjali, Wood Mary A, Mitin Timur, Thompson Reid F, James Nicholas D, Ward Douglas G, Bryan Richard T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cetuximab
Share to Chemoradiotherapy
Share to Clinical Trials, Phase I as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase II as Topic

Share to Liquid Biopsy

Share to Mitomycin

Share to Muscle, Smooth

Share to Receptor, Fibroblast Growth Factor, Type 3

Source

Identifiers

PMID: 34491610
DOI: 10.1111/bju.15589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study.PMID 34491610Read ↗

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer ManagementSemantic proximity Read ↗

Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary dataSemantic proximity Read ↗

Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with HematuriaSemantic proximity Read ↗

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read ↗

Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancerSemantic proximity Read ↗

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder CancerSemantic proximity Read ↗

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read ↗

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.Semantic proximity Read ↗

Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptationSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.